Cisplatin, 5-fluorouracil, and cetuximab (PFE) with or without cilengitide in recurrent/metastatic squamous cell carcinoma of the head and neck: results of the randomized phase I/II ADVANTAGE trial (phase II part)
| Autor: | Vermorken, J.B. *, Peyrade, F., Krauss, J., Mesía, R., Remenar, E., Gauler, T.C., Keilholz, U., Delord, J.P., Schafhausen, P., Erfán, J., Brümmendorf, T.H., Iglesias, L., Bethe, U., Hicking, C., Clement, P.M. |
|---|---|
| Zdroj: | In Annals of Oncology March 2014 25(3):682-688 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|